Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PPLs is a proprietary nutraceutical extract derived from Taiwanese Green Propolis (TGP), developed by NatureWise Biotech & Medicals Corporation. The extract is characterized by its high concentration of bioactive propolins (specifically propolins C, D, F, G, and H) and isoprenoid flavonoids, which are unique to propolis sourced from Taiwan. NatureWise utilizes a specialized extraction process to remove impurities such as wax and resin while enriching the active components. PPLs is primarily marketed as an oral supplement for immune support and general health maintenance. Scientific research into the extract has highlighted its neurotrophic, anti-inflammatory, antioxidant, and antimicrobial activities, with ongoing interest in its potential to manage type 2 diabetes and improve the quality of life for cancer patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PPLs.